Delivery Order SPE2DB22D2206-SPE2DB25FHD72
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4563772319 - AMBISOME 50 MG VIALS. The contract has a completion date of February 27, 2024 and a potential value of $2,517.84. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AmBisome 50 mg vials. The contract has a ceiling value of $4,523.90 and a completion date of May 20, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and a critical supplier of medical and pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AmBisome 50 mg vials. The contract has a firm fixed price of $34,749.46 and a period of performance ending on May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The delivery order has a potential value of $1,923.48 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the Department of Defense, providing pharmaceutical products and medical supplies to support military...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,035.68 order is for the delivery of AMBISOME 50 MG VIALS, a pharmaceutical product, with an ultimate completion date of April 2, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The $1,923.48 award is for pharmaceutical products to support military treatment programs and facilities, with a completion date of December 28, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, has a long history of providing pharmaceuticals, medical supplies, and related...
This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA). The $1,923.48 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a $3,846.96 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,153,581 units of AMBISOME 50 MG VIALS by December 21, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a long history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order was not set aside and is part of...
This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,105.57 firm-fixed-price contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of April 15, 2025....